Pharmaceutical - GlaxoSmithKline, Markets & Marketing

Filter

Popular Filters

1 to 25 of 79 results

Asthma drug market set to grow $23 billion by 2023

28-11-2014

The asthma treatment market value will grow across eight major countries (the USA, UK, France, Germany,…

AdvairAstraZenecaAustraliaEuropeGlaxoSmithKlineJapanMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicortUSA

Pharma companies can still improve access to medicines, report shows

Pharma companies can still improve access to medicines, report shows

17-11-2014

Top pharma companies are doing more to improve access to medicine in developing countries over the last…

GlaxoSmithKlineGlobalMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Most-used agents in US bipolar disorder treatment sector; report

Most-used agents in US bipolar disorder treatment sector; report

24-10-2014

Through analysis of US longitudinal patient-level claims data, Bristol-Myers Squibb and Otsuka’s Abilify…

AbilifyBristol-Myers SquibbCymbaltaDainippon Sumitomo PharmaEli LillyGlaxoSmithKlineLamotrigineLatudaMarkets & MarketingNeurologicalOtsukaPharmaceuticalUSA

Pfizer looks set to win $100 million Russian vaccines contract

16-10-2014

The Swiss unit of US pharma giant Pfizer has remained the only bidder for the 3.47 billion-rouble ($100…

GlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalPrevenarRussiaSynflorixVaccines

GlaxoSmithKline takes stake in new Aspen Japanese unit

GlaxoSmithKline takes stake in new Aspen Japanese unit

09-10-2014

South African drugmaker Aspen Pharmacare says that Aspen Global Inc, a subsidiary of Aspen Holdings,…

Aspen PharmacareGlaxoSmithKlineJapanMarkets & MarketingMergers & AcquisitionsPharmaceutical

Pfizer and GSK to compete for $120 million Russian pneumococcal vaccine contract

Pfizer and GSK to compete for $120 million Russian pneumococcal vaccine contract

08-10-2014

US pharma giant Pfizer and UK peer GlaxoSmithKline plan to compete for the 3.47 billion-rouble ($120…

GlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalPrevenarRussiaSynflorixVaccines

GlaxoSmithKline’s $490 million fine to spark pharma strategy shift in emerging markets, says analyst

GlaxoSmithKline’s $490 million fine to spark pharma strategy shift in emerging markets, says analyst

25-09-2014

UK pharma giant GlaxoSmithKline’s involvement in a large-scale bribery scandal in China came to an…

BrazilChinaGlaxoSmithKlineIndiaManagementMarkets & MarketingPharmaceutical

Type 2 diabetes market to increase to $47 billion in 2023

Type 2 diabetes market to increase to $47 billion in 2023

19-09-2014

As physicians continue to adopt a more individualized approach to patient care, branded type 2 diabetes…

BiosimilarsBoehringer IngelheimDiabetesEli LillyEuropeGlaxoSmithKlineInsulin Glargine [rDNA origin] InjectionJapanMarkets & MarketingNovo NordiskPharmaceuticalPricingTanzeumTrulicityUSAVictoza

Global asthma market to hit $18 billion by 2021 boosted by biologics

Global asthma market to hit $18 billion by 2021 boosted by biologics

14-08-2014

The market for asthma drugs is predicted to reach $18 billion by 2021, according to new research from…

AdvairAsthmaAstraZenecaBoehringer IngelheimBreoGlaxoSmithKlineGlobalMarkets & MarketingNatasha SpillerPharmaceuticalRespiratory and PulmonaryRespiratory therapySpirivaSymbicort

Pharmaceuticals, a strategic sector for the UK government

Pharmaceuticals, a strategic sector for the UK government

28-07-2014

Britain’s pharmaceuticals sector, which includes AstraZeneca and GlaxoSmithKline, two drugmakers among…

AstraZenecaEconomy of the United KingdomFinancialGlaxoSmithKlineMarkets & MarketingPharmaceuticalResearchUK

Global epileptic anticonvulsants market - 2014-2020

Global epileptic anticonvulsants market - 2014-2020

16-07-2014

North America dominates the global epileptic anticonvulsants market and is followed by Europe, according…

Abbott LaboratoriesAsia PacificBusiness FinanceEpilepsyGlaxoSmithKlineGlobalHealth Medical PharmaHealth Medical PharmaJohnson & JohnsonMarkets & MarketingNeurologicalNovartisPfizerPharmaceuticalUCB

US nephrologists view hyperphosphatemia treatment

US nephrologists view hyperphosphatemia treatment

11-07-2014

Surveyed nephrologists report awareness of the US Food and Drug Administration's approval of Vifor Fresenius…

AmgenFreseniusGlaxoSmithKlineLa Jolla PharmaceuticalMarkets & MarketingNephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeSensiparUSAvelcalcetideVelphoroVenoferVifor Pharma

GSK comments on media coverage of China problems

GSK comments on media coverage of China problems

30-06-2014

UK pharma giant GlaxoSmithKline, already the subject of allegations and investigations of wrongful marketing…

ChinaGlaxoSmithKlineManagementMarkets & MarketingPharmaceutical

EU5 payers looking to superior clinical efficacy for COPD

EU5 payers looking to superior clinical efficacy for COPD

30-06-2014

Surveyed pulmonologists in the European Union (EU5; France, Germany, Italy, Spain and the UK) estimate…

EuropeGlaxoSmithKlineMarkets & MarketingPharmaceuticalRelvarRespiratory and Pulmonary

US retinal specialists very receptive to pipeline agents for dry-AMD

US retinal specialists very receptive to pipeline agents for dry-AMD

05-06-2014

Surveyed US retinal specialists are highly willing to prescribe key emerging therapies for the treatment…

emixustatGlaxoSmithKlineGSK-933776Markets & MarketingOphthalmicsOtsukaPharmaceuticalResearchUSA

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

05-06-2014

UK pharma giant GlaxoSmithKline has agreed to a $105 million settlement with 44 US states and the District…

AdvairFinancialGlaxoSmithKlineLegalMarkets & MarketingNeurologicalPaxilPharmaceuticalRespiratory and PulmonaryUSAWellbutrin

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

28-05-2014

UK pharma giant GlaxoSmithKline, already subject to allegations of bribery of doctors and hospitals in…

GlaxoSmithKlineLegalMarkets & MarketingPharmaceuticalUK

Police close investigation on GlaxoSmithKline China's bribery case

Police close investigation on GlaxoSmithKline China's bribery case

14-05-2014

Chinese police have finished the investigation on the suspected bribery case of the local subsidiary…

ChinaGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

GSK confirms further misconduct allegations, now in Jordan and Lebanon

17-04-2014

There has been recent publicity on cases of alleged misconduct by UK Pharma giant GlaxoSmithKline employees…

GlaxoSmithKlineJordanMarkets & MarketingPharmaceuticalRegulationRest of the World

2014 “drugs to watch” as potential blockbusters

2014 “drugs to watch” as potential blockbusters

17-04-2014

The Thomson Reuters Intellectual Property & Science business has released its annual forecast of the…

AfrezzaAnoro ElliptaAnti-viralsCyramzaEli LillyGilead SciencesGlaxoSmithKlineidelalisibMannKindMarkets & MarketingOncologyPharmaceuticalRespiratory and PulmonarySovaldi

Factors driving oncologists’ prescribing decisions for HER2-positive breast cancer patients

Factors driving oncologists’ prescribing decisions for HER2-positive breast cancer patients

28-03-2014

Efficacy, more than any other factors, drives oncologists’ prescribing of targeted therapies for breast…

AfinitorbuparlisibGlaxoSmithKlineHerceptinMarkets & MarketingNovartisOncologyPerjetaPharmaceuticalRocheTykerb

Global epilepsy market to reach $4.5 billion by 2019

Global epilepsy market to reach $4.5 billion by 2019

13-03-2014

The epilepsy therapeutics market value in the eight major countries - the USA, Canada, France, Germany,…

EisaiFycompaGlaxoSmithKlineGlobalMarkets & MarketingNeurologicalPharmaceuticalTrobaltUCBVimpat

Asia-Pacific epilepsy therapeutics market continues to grow as new drugs emerge

28-02-2014

The epilepsy therapeutics market value in the Asia-Pacific region - Australia, China, India and Japan…

Asia-PacificEisaiFycompaGlaxoSmithKlineKeppraMarkets & MarketingNeurologicalPharmaceuticalTrobaltUCBVimpatZonegran

1 to 25 of 79 results

Back to top